Name | Number of supported studies | Average coverage | |
---|---|---|---|
astrocyte | 11 studies | 33% ± 13% | |
glutamatergic neuron | 9 studies | 45% ± 25% | |
oligodendrocyte precursor cell | 9 studies | 34% ± 15% | |
ciliated cell | 9 studies | 26% ± 10% | |
GABAergic neuron | 7 studies | 45% ± 22% | |
neuron | 7 studies | 28% ± 12% | |
endothelial cell | 7 studies | 33% ± 13% | |
amacrine cell | 6 studies | 26% ± 8% | |
retina horizontal cell | 6 studies | 33% ± 15% | |
interneuron | 5 studies | 50% ± 24% | |
retinal bipolar neuron | 4 studies | 26% ± 5% | |
granule cell | 4 studies | 25% ± 4% | |
retinal ganglion cell | 4 studies | 44% ± 18% | |
oligodendrocyte | 4 studies | 25% ± 3% | |
retinal cone cell | 3 studies | 31% ± 4% | |
retinal pigment epithelial cell | 3 studies | 35% ± 23% | |
Mueller cell | 3 studies | 31% ± 12% | |
GABAergic amacrine cell | 3 studies | 32% ± 15% | |
OFF-bipolar cell | 3 studies | 28% ± 7% | |
ON-bipolar cell | 3 studies | 26% ± 6% | |
glycinergic amacrine cell | 3 studies | 26% ± 9% | |
rod bipolar cell | 3 studies | 36% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 4000.88 | 2639 / 2642 | 100% | 17.73 | 703 / 705 |
kidney | 100% | 2107.22 | 89 / 89 | 93% | 6.74 | 834 / 901 |
prostate | 96% | 1462.97 | 236 / 245 | 95% | 6.04 | 479 / 502 |
adrenal gland | 100% | 2590.48 | 258 / 258 | 91% | 8.72 | 210 / 230 |
breast | 87% | 1069.40 | 401 / 459 | 89% | 6.50 | 995 / 1118 |
thymus | 86% | 914.02 | 559 / 653 | 86% | 4.55 | 523 / 605 |
lung | 94% | 1183.12 | 543 / 578 | 56% | 2.80 | 647 / 1155 |
pancreas | 99% | 1527.99 | 325 / 328 | 50% | 2.06 | 89 / 178 |
intestine | 96% | 2331.34 | 932 / 966 | 35% | 1.49 | 186 / 527 |
stomach | 96% | 2140.03 | 345 / 359 | 36% | 1.58 | 102 / 286 |
skin | 27% | 212.23 | 486 / 1809 | 93% | 10.05 | 441 / 472 |
ovary | 22% | 184.11 | 39 / 180 | 96% | 6.39 | 411 / 430 |
uterus | 78% | 957.47 | 133 / 170 | 30% | 2.16 | 138 / 459 |
spleen | 100% | 1448.02 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.07 | 1 / 1 |
blood vessel | 100% | 4666.14 | 1330 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 95% | 7.67 | 76 / 80 |
bladder | 62% | 830.90 | 13 / 21 | 31% | 1.46 | 154 / 504 |
esophagus | 64% | 2407.01 | 928 / 1445 | 20% | 1.05 | 37 / 183 |
adipose | 77% | 699.63 | 924 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 76% | 3.04 | 22 / 29 |
heart | 60% | 477.94 | 519 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 19% | 722.27 | 179 / 929 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 16% | 0.78 | 65 / 406 |
tonsil | 0% | 0 | 0 / 0 | 9% | 0.43 | 4 / 45 |
muscle | 2% | 11.18 | 14 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0030182 | Biological process | neuron differentiation |
GO_0014902 | Biological process | myotube differentiation |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0003729 | Molecular function | mRNA binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | MYEF2 |
Protein name | Myelin expression factor 2 (MEF-2) (MyEF-2) (MST156) Myelin expression factor 2 |
Synonyms | KIAA1341 hCG_40072 |
Description | FUNCTION: Transcriptional repressor of the myelin basic protein gene (MBP). Binds to the proximal MB1 element 5'-TTGTCC-3' of the MBP promoter. Its binding to MB1 and function are inhibited by PURA (By similarity). . |
Accessions | H0YN19 ENST00000620867.4 ENST00000560172.5 A0A0C4DGV1 ENST00000267836.10 A0A0A0MR39 Q9P2K5 ENST00000324324.12 H0YKS1 A0A0A0MQW0 ENST00000561151.1 [Q9P2K5-4] ENST00000561351.5 [Q9P2K5-4] ENST00000558395.1 |